Dashboard
1
High Debt Company with a Debt to Equity ratio (avg) at times
- Poor long term growth as Net Sales has grown by an annual rate of 10.60% and Operating profit at -3.06% over the last 5 years
- High Debt Company with a Debt to Equity ratio (avg) at times
- The company has been able to generate a Return on Equity (avg) of 14.45% signifying low profitability per unit of shareholders funds
2
Poor long term growth as Net Sales has grown by an annual rate of 10.60% and Operating profit at -3.06% over the last 5 years
3
The company has declared Negative results for the last 3 consecutive quarters
4
With ROE of 8.50%, it has a very expensive valuation with a 1.84 Price to Book Value
5
Consistent Underperformance against the benchmark over the last 3 years
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-14.56%
0%
-14.56%
6 Months
-25.33%
0%
-25.33%
1 Year
-45.94%
0%
-45.94%
2 Years
-57.43%
0%
-57.43%
3 Years
-62.5%
0%
-62.5%
4 Years
-74.07%
0%
-74.07%
5 Years
-79.26%
0%
-79.26%
LBX Pharmacy Chain JSC for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
9.24%
EBIT Growth (5y)
0.16%
EBIT to Interest (avg)
7.30
Debt to EBITDA (avg)
2.29
Net Debt to Equity (avg)
0.89
Sales to Capital Employed (avg)
1.50
Tax Ratio
26.26%
Dividend Payout Ratio
81.48%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
10.47%
ROE (avg)
14.45%
Valuation key factors
Factor
Value
P/E Ratio
13
Industry P/E
Price to Book Value
1.30
EV to EBIT
14.96
EV to EBITDA
6.61
EV to Capital Employed
1.17
EV to Sales
0.64
PEG Ratio
0.77
Dividend Yield
1.72%
ROCE (Latest)
7.81%
ROE (Latest)
10.38%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
Bearish
Bearish
OBV
Mildly Bearish
Mildly Bearish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY
Mar'26
Mar'25
Change(%)
Net Sales
5,481.30
5,435.20
0.85%
Operating Profit (PBDIT) excl Other Income
399.30
788.20
-49.34%
Interest
28.00
37.80
-25.93%
Exceptional Items
0.00
0.00
Consolidate Net Profit
302.40
287.70
5.11%
Operating Profit Margin (Excl OI)
72.90%
70.80%
0.21%
USD in Million.
Net Sales
YoY Growth in quarter ended Mar 2026 is 0.85% vs -1.88% in Mar 2025
Consolidated Net Profit
YoY Growth in quarter ended Mar 2026 is 5.11% vs -21.46% in Mar 2025
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
22,185.50
22,303.50
-0.53%
Operating Profit (PBDIT) excl Other Income
2,653.80
2,776.10
-4.41%
Interest
143.80
191.90
-25.07%
Exceptional Items
-232.10
-103.60
-124.03%
Consolidate Net Profit
540.40
685.10
-21.12%
Operating Profit Margin (Excl OI)
46.70%
50.20%
-0.35%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is -0.53% vs -0.38% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is -21.12% vs -39.03% in Dec 2024
About LBX Pharmacy Chain JSC 
LBX Pharmacy Chain JSC
Retailing
No Details Available.
Company Coordinates 
No Company Details Available






